BLRX
Bioline RX Ltd Sponsored ADR · NASDAQ
- Sector Health Technology
- Industry Pharmaceuticals: Major
- Website biolinerx.com
- Employees(FY) 49
- ISIN US09071M2052
Performance
-8.53%
1W
-13.23%
1M
-45.44%
3M
-56.5%
6M
-60.38%
YTD
-54.93%
1Y
Profile
BioLineRx Ltd., a pre-commercial-stage biopharmaceutical company, focuses on oncology. The company develops Motixafortide, a peptide, which has completed Phase 3 clinical trials for the treatment of autologous stem cell mobilization and Phase 2a clinical trials for the treatment of pancreatic cancer; and that is in Phase 2 clinical trials for the treatment of metastatic pancreatic adenocarcinoma patients, and Phase 1b clinical trials in patients with acute respiratory distress syndrome secondary to COVID-19 and other respiratory viral infections, as well as for the treatment of solid tumors and acute myeloid leukemia. It is also developing AGI-134, an immuno-oncology agent, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and BL-5010, a customized, proprietary, pen-like applicator for the non-surgical removal of skin lesions. The company has collaboration agreement with MSD for the cancer immunotherapy field; and MD Anderson Cancer Center to investigate the combination of Motixafortide with KEYTRUDA (pembrolizumab) in pancreatic cancer, as well as licensing arrangement with Perrigo Company plc for over-the-counter sale of BL-5010. BioLineRx Ltd. was incorporated in 2003 and is headquartered in Modi'in, Israel.
Technical Analysis of BLRX 2024-05-10
Overview:
In the last 5 trading days, BLRX has shown a downward trend in its stock price, accompanied by decreasing trading volumes. The moving averages indicate a bearish sentiment, with the stock price consistently below the short-term moving averages. Momentum indicators suggest a weakening trend, while volatility indicators show a narrowing ...
Recent News & Updates
- 2024-05-05 19:00
- 2024-04-16 19:00
- 2024-04-09 19:00
- 2024-03-31 21:00
- 2024-03-27 00:23
- 2024-03-25 19:00
- 2024-03-19 19:00
- 2024-03-05 19:00
- 2024-03-03 18:00
- 2024-02-27 18:00
- 2024-02-25 01:12
3 Top Penny Stocks for 5,000% Upside in 2024 and Beyond(Yahoo Finance)
- 2024-02-15 18:00
- 2023-12-20 18:00
- 2023-11-21 02:45
- 2023-11-19 18:00
- 2023-11-12 18:00
- 2023-11-02 03:12
3 Tech Stocks That Wall Street Loves More Than Nvidia(Yahoo Finance)
- 2023-10-30 21:00
- 2023-10-29 23:38
3 Top Penny Stocks to Make You a Millionaire in 5 Years(Yahoo Finance)
- 2023-10-11 19:00
- 2023-09-27 19:00
- 2023-09-18 19:00
- 2023-09-13 17:36
BLRX: Go!(Yahoo Finance)
- 2023-09-10 19:00
- 2023-09-04 18:04
BLRX: On Your Marks, Get Set(Yahoo Finance)
- 2023-08-30 20:18
- 2023-08-29 19:00
- 2023-08-21 19:00
- 2023-08-07 02:34
3 Cheap Biotech Stocks That Smart Investors Will Snap Up Now(Yahoo Finance)
- 2023-07-18 03:22
3 Smart Penny Stocks with Huge Potential(Yahoo Finance)
Page 1 of 4
previousnext